Related Experiment Video
Updated: Jun 7, 2025
13:01
Anti-Nuclear Antibody Screening Using HEp-2 Cells
Published on: June 23, 2014
134.5K
Seronegative Antiphospholipid Syndrome: A Challenging Case Report.
Eihab A Subahi1, Soha Aboukhalaf1, Shahd Mohammedain2
1Department of General Internal Medicine Hamad Medical Corporation Doha Qatar.
Clinical Case Reports
|November 19, 2024
Summary
Seronegative antiphospholipid syndrome (SN-APS) is a rare cause of stroke in young adults. Early diagnosis of SN-APS is vital for effective antithrombotic treatment and preventing recurrent arterial thrombosis.
Area of Science:
- Internal Medicine
- Neurology
- Rheumatology
Background:
- Seronegative antiphospholipid syndrome (SN-APS) is an uncommon condition.
- It presents diagnostic challenges and can lead to arterial thrombosis.
- SN-APS should be considered in the differential diagnosis of stroke, particularly in young individuals.
Purpose of the Study:
- To highlight the importance of considering SN-APS in young stroke patients.
- To emphasize the diagnostic challenges and recognition of SN-APS.
- To underscore the necessity of appropriate antithrombotic treatment for SN-APS.
Main Methods:
- Diagnosis of SN-APS is typically made by exclusion.
- Clinical evaluation for arterial thrombosis in young patients.
- Assessment of risk factors and exclusion of other causes.
Main Results:
- SN-APS can manifest as arterial thrombosis, including stroke.
- Recognition of SN-APS is crucial for guiding treatment decisions.
- Timely diagnosis can help reduce the rate of recurrent events.
Conclusions:
- SN-APS is an important, albeit uncommon, cause of arterial thrombosis in young individuals.
- Differential diagnosis of stroke in the young should include SN-APS.
- Appropriate antithrombotic therapy is essential for managing SN-APS and preventing recurrence.
